small molecule

CHILDREN'S ALLEGRA HIVES

FEXOFENADINE HYDROCHLORIDE

Loss of exclusivityAugust 2030latest FDA-listed patent expiry
CompanyCHATTEM INC DBA SANOFI CONSUMER HEALTHCARE

Drug detail

Brand nameCHILDREN'S ALLEGRA HIVES
Active ingredientFEXOFENADINE HYDROCHLORIDE
Strength30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formSUSPENSION
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2011
Marketing statusDISCN

Listed patents

PatentExpiresType
8933097August 2030product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

CHILDREN'S ALLEGRA HIVES patent cliff — loss of exclusivity August 2030 | CliffBio